Merck and Moderna’s personalized melanoma vaccine has met key goals in a large Phase 3 trial. The mRNA-based treatment was tested with Merck’s Keytruda in high-risk melanoma patients. The companies said the combination significantly improved...
Ultragenyx Pharmaceutical’s gene therapy Genglycos has received U.S. FDA approval for glycogen storage disease type Ia (GSDIa). The gene therapy is the first FDA-approved treatment for the rare metabolic disorder. GSDIa, also known as Von Gierke...
Ebola cases in the Democratic Republic of Congo (DRC) have crossed 5,000, marking a new and alarming phase in the country’s fastest-growing Ebola outbreak. Government data showed 5,021 confirmed cases as of August 16, along with 2,378 deaths.
Plaque psoriasis patients in India may soon have a new treatment option. Optimus Pharma has received approval from the Drug Controller General of India (DCGI). The approval covers Tapinarof Cream 1% w/w for adult patients with plaque psoriasis.
Lung cancer trial development at AstraZeneca has hit a setback. The company discontinued its Phase III eVOLVE-Lung02 study of volrustomig with chemotherapy in metastatic non-small cell lung cancer
Lupin has received a key FDA approval that strengthens its position in sleep disorder drugs. The approval covers its generic Pitolisant Tablets for the US market. The latest regulatory clearance allows Lupin to market Pitolisant Tablets in 4.45 mg...
Telangana has brought its Food Safety Department and Drugs Control Administration under one administrative structure called the Telangana Standards Authority for Food and Essential Drugs
Drug Resistance is becoming harder to manage as bacteria stop responding to commonly used antibiotics. Wockhardt is now targeting this challenge through a new scientific learning platform.
India’s TB screening drive has uncovered a major number of cases, highlighting the scale of hidden tuberculosis. More than 2.2 crore people were screened during the 100-day campaign, with over 7 lakh TB cases detected. Union Health Minister...
Fertility drug regulation has come under scrutiny after the Central Drugs Standard Control Organization flagged the unauthorized manufacture